Delivery Order SPE2DB20D9214-SPE2DB24FD4UZ

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of PREVNAR 20 SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $7,088.88 and a period of performance through July 9, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of PREVNAR 20 SYRINGE 0.5ML. The contract has a ceiling value of $18,526.00 and a period of performance through July 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $17,722.20, is for the delivery of PREVNAR 20 SYRINGE 0.5ML, a pharmaceutical product, with a completion date of July 8, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of PREVNAR 20 Syringe 0.5ML, a pharmaceutical product, and has a ceiling value of $7,088.88. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $35,447.20, is for the delivery of Prevnar 20 syringes. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,772.36, is for the delivery of PREVNAR 20 vaccine syringes (0.5 mL) to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a $3,544.74 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Prevnar 20 syringe 0.5 ML to support the recurring medical supply needs of military health facilities. It is associated with a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $177,236.00 order is for the delivery of PREVNAR 20 SYRINGE 0.5ML, a pneumococcal conjugate vaccine, with a period of performance through July 10, 2024. The award is issued against a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,722.20, is for the delivery of PREVNAR 20 SYRINGE 0.5ML, a pediatric pneumococcal vaccine, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of July 8, 2024 and is not associated with any...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,544.44 contract is for the delivery of PREVNAR 20 SYRINGE 0.5ML, a pneumococcal vaccine product, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of July 10, 2024 and is not associated with any set-aside designation....
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4UZ
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PREVNAR 20 SYRINGE 0.5ML, a specialized pharmaceutical product, with a ceiling value of $17,722.20 and a completion date of July 9, 2024.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.

Generated 5/17/25, 10:07 AM